DE60322254D1 - Imidazolderivate als faktor-xa-inhibitoren - Google Patents

Imidazolderivate als faktor-xa-inhibitoren

Info

Publication number
DE60322254D1
DE60322254D1 DE60322254T DE60322254T DE60322254D1 DE 60322254 D1 DE60322254 D1 DE 60322254D1 DE 60322254 T DE60322254 T DE 60322254T DE 60322254 T DE60322254 T DE 60322254T DE 60322254 D1 DE60322254 D1 DE 60322254D1
Authority
DE
Germany
Prior art keywords
inhibitors
factor
imidazole derivatives
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322254T
Other languages
German (de)
English (en)
Inventor
Marc Nazare
Armin Bauer
Volkmar Wehner
David William Will
Hans Matter
Michael Wagner
Herman Schreuder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02027120A external-priority patent/EP1426364A1/en
Priority claimed from EP03011307A external-priority patent/EP1479674A1/en
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Application granted granted Critical
Publication of DE60322254D1 publication Critical patent/DE60322254D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60322254T 2002-12-04 2003-11-20 Imidazolderivate als faktor-xa-inhibitoren Expired - Lifetime DE60322254D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027120A EP1426364A1 (en) 2002-12-04 2002-12-04 Imidazole-derivatives as factor Xa inhibitors
EP03011307A EP1479674A1 (en) 2003-05-19 2003-05-19 Imidiazole-derivatives as factor xa inhibitors
PCT/EP2003/012996 WO2004050636A2 (en) 2002-12-04 2003-11-20 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS

Publications (1)

Publication Number Publication Date
DE60322254D1 true DE60322254D1 (de) 2008-08-28

Family

ID=32471891

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322254T Expired - Lifetime DE60322254D1 (de) 2002-12-04 2003-11-20 Imidazolderivate als faktor-xa-inhibitoren

Country Status (12)

Country Link
EP (1) EP1569927B1 (enExample)
JP (1) JP4504820B2 (enExample)
AR (1) AR042261A1 (enExample)
AT (1) ATE401322T1 (enExample)
AU (1) AU2003285336B2 (enExample)
BR (1) BR0317003A (enExample)
CA (1) CA2507624A1 (enExample)
DE (1) DE60322254D1 (enExample)
MX (1) MXPA05005498A (enExample)
PE (1) PE20040700A1 (enExample)
TW (1) TW200504027A (enExample)
WO (1) WO2004050636A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372050B (en) 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
WO2006047415A2 (en) 2004-10-26 2006-05-04 Janssen Pharmaceutica, N.V. Factor xa compounds
US8110573B2 (en) 2004-12-30 2012-02-07 Astex Therapeutics Limited Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
JP5474354B2 (ja) 2005-12-30 2014-04-16 アステックス、セラピューティックス、リミテッド 医薬化合物
JP5523829B2 (ja) 2006-06-29 2014-06-18 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2009105504A2 (en) 2008-02-21 2009-08-27 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 有害生物防除剤としての新規複素環式化合物
CN114105881B (zh) * 2020-08-31 2024-01-26 沈阳海诺威医药科技有限公司 血小板聚集抑制剂及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
WO2001032628A1 (en) * 1999-11-03 2001-05-10 Bristol-Myers Squibb Pharma Company Cyano compounds as factor xa inhibitors
WO2002000651A2 (en) * 2000-06-27 2002-01-03 Bristol-Myers Squibb Pharma Company Factor xa inhibitors

Also Published As

Publication number Publication date
BR0317003A (pt) 2005-10-25
AU2003285336A1 (en) 2004-06-23
WO2004050636A3 (en) 2004-10-14
EP1569927B1 (en) 2008-07-16
WO2004050636A2 (en) 2004-06-17
TW200504027A (en) 2005-02-01
JP4504820B2 (ja) 2010-07-14
EP1569927A2 (en) 2005-09-07
CA2507624A1 (en) 2004-06-17
ATE401322T1 (de) 2008-08-15
PE20040700A1 (es) 2004-11-25
AR042261A1 (es) 2005-06-15
JP2006514093A (ja) 2006-04-27
MXPA05005498A (es) 2005-07-25
AU2003285336B2 (en) 2009-11-26

Similar Documents

Publication Publication Date Title
ATE444292T1 (de) Pyrazolderivate als faktor-xa-inhibitoren
DE60315862D1 (de) Dihydropyridinonderivate als hne-inhibitoren
DE60330227D1 (de) N3-alkylierte benzimidazol-derivate als mek-hemmer
DE60329282D1 (de) Cyano-pyrrolidine als DPP-IV Inhibitoren
DE60325032D1 (de) 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
ATE489387T1 (de) Pyridoä2,1-aü-isochinolinderivate als dpp-iv inhibitoren
ATE426599T1 (de) Thiazolylpiperidin derivate als mtp inhibitoren
IS7625A (is) Nýjar samrunnar imídazól afleiður
ATE404564T1 (de) Diazepinoindolderivate als kinaseinhibitoren
ATE437876T1 (de) Hexahydropyridoisochinoline als dpp-iv- inhibitoren
DE60315516D1 (de) Pyridazinon-derivate als cdk2-hemmer
DE60313872D1 (de) Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
DK1490355T3 (da) Indolylmaleimidderivater
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
DE602004024420D1 (de) Chinazolinderivate als antitumormittel
DE602004008303D1 (de) Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
ATE529428T1 (de) Thioxanthinderivate als myeloperoxidaseinhibitoren
DE60308670D1 (de) Substituierte indole als alpha-1 agonisten
ATE420076T1 (de) Indozolonderivate als 11b-hsd1-inhibitoren
ATE393159T1 (de) Heterobicyclische pyrazolderivate als kinaseinhibitoren
ATE538787T1 (de) Benzimidazol-derivative als raf-kinase-hemmer
DE60203529D1 (de) Indolderivate als cox-ii-inhibitoren
ATE402700T1 (de) Glycinamid-derivate als raf-kinase-hemmer
ATE386737T1 (de) Imidazol-derivate als tafia-inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition